RAB27A and colorectal cancer: Rab27a knockout suppressed colorectal cancer growth and extended survival in MC38 mice, which is a colorectal cancer model exhibiting a partial response to anti-PD-L1 therapy (Deng et al., 2014; Poggio et al., 2019).